GARD Steering committee report J Bousquet, R Dahl
description
Transcript of GARD Steering committee report J Bousquet, R Dahl
GARD
Steering committee reportJ Bousquet, R Dahl
Steering committee report1- Consequences for GARD of the publication
of the WHO Chronic Disease report2- GARD members3- Modified TOR
4- Preparation of the Launch5- "GARD manual"
6- Dissemination of GARD to countries
GARD Stepwise approachMay 2005
GARD priorities
Integrated GARD action plan
Step 1Step 2
Step 3
2005 2006 2007 2008 2009 2010
Pilot studies in countries
GARD action plan in countries
GARD priorities
Integrated GARD action plan
Step 1Step 2
Step 3
2005 2006 2007 2008 2009 2010
Pilot studies in countries
GARD action plan in countries
GARD Stepwise approachMarch 2006
Steering committee report1- Consequences for GARD of the publication
of the WHO Chronic Disease report
October 5, 2005
QuickTime™ et undécompresseur TIFF (LZW)
sont requis pour visionner cette image.
Estimate population needs and advocate
WG.1- Burden, risk factors and surveillance (G Viegi, S Buist, Y Fukuchi)
WG.2- Awareness and advocacy (C Lenfant, A Turnbull, P van Cauwenberge)
Formulate and adopt policyWG.3- Prevention and health promotion (M Boland, A
Custovic)
WG.4- Diagnosis of CRD (K Rabe, S Wenzel) WG.5- Control of CRD and allergies,
Availability and affordability of drugs (J Bousquet, E Bateman, L Fabbri, C van Weel)
WG.6- Pediatric asthma (C Baena-Cagnani, E Mantzouranis, FER Simons, E Valovirta)
Formulate and adopt policyWG.3- Prevention and health promotion (M Boland, A
Custovic)
WG.4- Diagnosis of CRD (K Rabe, S Wenzel) and allergy (GW Canonica)
WG.5- Control of CRD and allergies, Availability and affordability of drugs
(J Bousquet, E Bateman, L Fabbri, C van Weel)
WG.6- Pediatric asthma (C Baena-Cagnani, E Mantzouranis, FER Simons, E Valovirta)
Formulate and adopt policyWG.3- Prevention and health promotion (M Boland, A
Custovic)
WG.4- Diagnosis of CRD (K Rabe, S Wenzel) and allergy (GW Canonica)
WG.5- Control of CRD and allergies (J Bousquet, E Bateman, L Fabbri, C van Weel)
Availability and affordability of drugs (N Aït Khaled)
WG.6- Pediatric asthma (C Baena-Cagnani, E Mantzouranis, FER Simons, E Valovirta)
In high income countries- patients can receive adequate diagnosis and treatment - but they are insufficiently diagnosed and treated- a disease-specific approach is needed- the goals of GARD are to better diagnose, treat and educate patients
In upper-middle income countries- few patients can receive adequate diagnosis and treatment the first goals of GARD are to reduce under-diagnosis - the second goals of GARD are to provide accessible and affordable treatment for all patients - a syndromic approach (PAL) is needed in many places
In lower-middle and low income countries- very few patients can receive adequate diagnosis and treatment the first goals of GARD are to reduce under-diagnosis - the second goals of GARD are to provide accessible and affordable treatment for all patients - a syndromic approach (PAL) is needed in most places
In all countries, health promotion and prevention are essential control by disease-specific approach control by syndromic approach no control
Current management of CRDCurrent management of CRD
In high income countries- patients can receive adequate diagnosis and treatment - but they are insufficiently diagnosed and treated- a disease-specific approach is needed- the goals of GARD are to better diagnose, treat and educate patients
In upper-middle income countries- few patients can receive adequate diagnosis and treatment - the first goals of GARD are to reduce under-diagnosis - the second goals of GARD are to provide accessible and affordable treatment for all patients - a syndromic approach (PAL) is needed in many places
In lower-middle and low income countries- very few patients can receive adequate diagnosis and treatment- the first goals of GARD are to reduce under-diagnosis - the second goals of GARD are to provide accessible and affordable treatment for all patients - a syndromic approach (PAL) is needed in most places
In all countries, health promotion and prevention are essential control by disease-specific approach control by syndromic approach no control
GARD policyGARD policy
Identify Policy Implementation Steps
National Coordination: • The GARD action plan should be applied at the country level • Establish national working groups with a national coordinator• The national coordination group will:
• Provide existing national statistics on CRD and allergies• Assess the specific needs for the given country • Review the GARD action plan • Determine the relevant issues for the country action plan • Develop a country-specific action plan
Steering committee report1- Consequences for GARD of the publication
of the WHO Chronic Disease report2- GARD members
WHO calls for a global and coordinated effortto fight chronic respiratory diseases
WE ARE GARD!
GARD members
Governmental organizationsScientific societiesPatient's organizationsOther NGOs
Pharmaceutical industryGovernments
Year 1 Year 2
"Medical" Foundations
GARD members
Governmental organizationsScientific societiesPatient's organizationsOther NGOs
Pharmaceutical industryGovernments
Year 1 Year 2
"Medical" Foundations
Targetted approachTargetted approach
GARD members
Governmental organizationsScientific societiesPatient's organizationsOther NGOs
Pharmaceutical industryGovernments
Year 1 Year 2
World BankUnesco and others
Private sector
"Medical" Foundations
Foundations
GARD members
Governmental organizationsScientific societiesPatient's organizationsOther NGOs
Pharmaceutical industryGovernments
Year 1 Year 2
World BankUnesco and others
Private sector
"Medical" Foundations
Foundations
Targetted approach firstTargetted approach first
Global approach laterGlobal approach later
Steering committee report1- Consequences for GARD of the publication
of the WHO Chronic Disease report2- GARD members3- Modified TOR
GARD TOR
• TOR december 2004: approved by members• Assembly meeting: revision of TOR NOT sent to WHO• to include private sector, WHO proposed a revised TOR (TOR2) (january 2006)• TOR2 should be discussed during the meeting and proposal sent to WHO
Steering committee report1- Consequences for GARD of the publication
of the WHO Chronic Disease report2- GARD members3- Modified TOR
4- Preparation of the Launch
Fact sheet
"Hundreds of millions of people suffer from chronic respiratory diseases worldwide, including:
o 300 million people with asthmao 62 million people with moderate to severe COPDo Millions of others with mild COPD, allergic rhinitis, and other chronic respiratory diseases, which are often undiagnosed."
Chronic respiratory diseases asthma 300 millions GINA, 2004
Moderate to severe COPD 62 millions WHO, 2006Allergic rhinitis millions Secondary pulmonary hypertension Occupational CRD Chronic rhinosinusitis Post-infectious CRD Lung cancer and neoplasms of the respiratory organsSequellae of pulmonary embolism Cor pulmonale Sleep apnea syndrome Lung fibrosis
TOTAL: Hundreds of millions
Chronic respiratory diseases asthma 300 millions GINA, 2004
COPD 150 millions Allergic rhinitis 400 millions Secondary pulmonary hypertension 25 millionsOccupational CRD 25 millionsChronic rhinosinusitis 50 millionsPost-infectious CRD No dataLung cancer and neoplasms of the respiratory organsSequellae of pulmonary embolism No dataCor pulmonale No dataSleep apnea syndrome 100 millionsLung fibrosis No data
TOTAL: > ONE BILLION
Steering committee report1- Consequences for GARD of the publication
of the WHO Chronic Disease report2- GARD members3- Modified TOR
4- Preparation of the Launch5- "GARD manual"
Geneva« pre-GARD »WHO meeting
GARDaccepted by WHO
1st GARDassembly
1st GARD/WHOmeeting
GARDmeeting
GARDLaunch
06-04 09-04 01-05 05-05 09-05 28-03-06
GARD GARD manualmanual
Geneva« pre-GARD »WHO meeting
GARDaccepted by WHO
1st GARDassembly
1st GARD/WHOmeeting
GARDmeeting
GARDLaunch
06-04 09-04 01-05 05-05 09-05 28-03-06
GARD GARD manualmanual
GARD source document
Fact sheetsPress release
Geneva« pre-GARD »WHO meeting
GARDaccepted by WHO
1st GARDassembly
1st GARD/WHOmeeting
GARDmeeting
GARDLaunch
06-04 09-04 01-05 05-05 09-05 28-03-06
GARD GARD manualmanual
GARD source document
Public Healthguide
Pocket guide
ReviewPublished by NGOs
Launch at ERS
Steering committee report1- Consequences for GARD of the publication
of the WHO Chronic Disease report2- GARD members3- Modified TOR
4- Preparation of the Launch5- "GARD manual"
6- Dissemination of GARD to countries
Activities within countriesActivities within countries• ChinaChina: launch, Chinese Medical Association: launch, Chinese Medical Association• BrazilBrazil: Minister of Health (PAHO): Minister of Health (PAHO)• PolandPoland: Minister of Health: Minister of Health• IndiaIndia: President: President• Japan, Korea..Japan, Korea..: National coordination: National coordination• Cape Verde, Russia, TunisiaCape Verde, Russia, Tunisia: Pilot studies: Pilot studies